Considerations about the Correct Nomenclature of Glycosaminoglycans (GAGs)

• References

• 1 Nielsen JI. A convienient method for molecular mass determination of heparin. Thromb Haemostas 1992; 68: 478-480
• 2 Harenberg J, De Vries JX. Characterisation of heparins by high-performance size exclusion liquid chromatography. J Chromatogr 1983; 261: 287-292
• 3 Malsch R, Harenberg J. Analysis of acid mucopolysaccharides by hplc techniques. Krankenhauspharmazie 1992; 12: 567-575
• 4 Fareed J, Walenga JM, Hoppensteadt D, Huan X, Nonn J. Biochemical and pharmacologic inequivalence of low molecular weight heparins. Ann NY Acad Sci 1989; 556: 333-351
• 5 Linhardt RJ, Loganathan D, Hakim AA, Wang HM, Walenga JM, Hoppensteadt D, Fareed J. Oligosaccharide mapping of low molecular weight heparins: structure and activity differences. J Med Chem 1990; 33: 1639-1645
• 6 Casu B. Structure of heparin and heparin fragments. Ann NY Acad Sci 1989; 556: 1-18
• 7 Sharon N. In IUPAC IUB Joint Commission on biochemical nomenclature, nomenclature of glycoproteins glycopeptides and peptidoglycans, recommendations. J Biol Chem 1985; 262: 13-18
• 8 Lindahl U. Approaches to the synthesis of heparin. Haemostasis 1990; 20 (Suppl. 01) 146-153
• 9 Van Dedem G, Nielsen JL. Determination of the molecular mass of low molecular mass (LMM) heparin. Pharmeuropa 1991; 3: 161-165
• 10 Kristensen HI, Thromborg EM, Nielsen JR, Johonsen KB, Ostergard PB. Development and validation of a size exclusion chromatography method for determination of molecular mass and molecular mass distribution in low molecular weight heparin. Thromb Res 1991; 64: 131-141
• 11 Jaques LB. Simplified and rational nomenclature for heparins, glycosaminoglycans and sulfated mucopolysaccharides. Artery 1978; 4: 144-156